Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Date   Title
Milan, 5 March 2010   Recordati: 2009 accounts approved by the board. Net income € 110.6 million. Dividend per share € 0.275 (+10%)
Milan, 11 February 2010   Recordati: preliminary full year 2009 results in line with targets: revenues +8.4%, net income +10.1%
Milan, 3 February 2010   Recordati: silodosin (Urorec®/Silodix™) approved by the European Commission for the treatment of the signs and symptoms of BPH
 
  Top